Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
Most Cited Paper
in Alzheimer's disease research and treatments
18 Months Post-Publication
Class of 2026
“Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
semaglutide · GLP-1 receptor agonist · type 2 diabetes mellitus · Alzheimer's disease · target trial emulation · electronic health records · nationwide real-world data · neurodegeneration · Neuroinflammation · Cox proportional hazards model · Kaplan-Meier survival analysis · insulin comparator · antidiabetic medications comparison · first-time AD diagnosis · obesity status subgroup analysis · AD-related medication prescriptions · hazard ratio · TriNetX database · GLP-1RA class comparison · neuroprotection
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Alzheimer's disease research and treatments Papers, Class of 2026. https://pri.pepkio.com/top-papers/alzheimer-s-disease-research-and-treatments/2026. Accessed 2026-07-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459